MeSH term
Frequency | Condition_Probility | Adult | 9 | 0.0 |
Humans | 46 | 0.0 |
Male | 22 | 0.0 |
*Alleles | 4 | 0.0 |
Animals | 12 | 0.0 |
Base Sequence | 13 | 0.0 |
COS Cells | 2 | 0.0 |
Cerebroside-Sulfatase/*genetics/metabolism | 4 | 100.0 |
Leukodystrophy, Metachromatic/enzymology/*genetics | 4 | 80.0 |
Molecular Sequence Data | 14 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
*Mutation | 8 | 0.0 |
Child, Preschool | 10 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
Chromosomes, Human, Pair 22/*genetics | 2 | 2.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Phenotype | 6 | 0.0 |
*Ring Chromosomes | 2 | 6.0 |
Comparative Study | 5 | 0.0 |
Female | 17 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Rats | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Species Specificity | 3 | 0.0 |
Steryl-Sulfatase | 2 | 1.0 |
Temperature | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Homozygote | 3 | 0.0 |
Lysosomes/enzymology | 3 | 4.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Mice | 3 | 0.0 |
Adolescent | 7 | 0.0 |
Child | 11 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
*Chromosomes, Human, Pair 22 | 5 | 2.0 |
Karyotyping | 3 | 0.0 |
Mental Retardation/genetics | 2 | 1.0 |
Polymerase Chain Reaction | 5 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Cerebroside-Sulfatase/*genetics | 10 | 100.0 |
Genetic Markers | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Alleles | 6 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Gene Frequency | 4 | 0.0 |
Infant | 9 | 0.0 |
Mutation | 4 | 0.0 |
Sulfoglycosphingolipids/urine | 2 | 100.0 |
Heterozygote | 2 | 0.0 |
Pedigree | 7 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Genotype | 3 | 0.0 |
Cell Line | 3 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Leukodystrophy, Metachromatic/*genetics | 6 | 100.0 |
Haplotypes | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
*Point Mutation | 4 | 0.0 |
Cerebroside-Sulfatase/*deficiency/genetics | 3 | 100.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
*Chromosome Deletion | 3 | 0.0 |
Consensus Sequence | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Exons | 2 | 0.0 |
Leukodystrophy, Metachromatic/*enzymology/*genetics | 2 | 100.0 |
Cerebroside-Sulfatase/genetics/*metabolism | 2 | 66.0 |
Hamsters | 4 | 0.0 |
DNA Primers | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Sulfatases/*genetics | 3 | 15.0 |
Genes, Structural | 2 | 0.0 |
Leukodystrophy, Metachromatic/enzymology/genetics | 2 | 100.0 |
Infant, Newborn | 2 | 0.0 |
*Chromosomes, Human, 21-22 and Y | 3 | 16.0 |
Hybrid Cells | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
X Chromosome | 2 | 0.0 |
Aged | 2 | 0.0 |
